Cetilistat (ATL-962) (Synonyms: ATL-962) |
| Katalog-Nr.GC31374 |
Cetilistat (ATL-962) (ATL-962), ein Inhibitor der Pankreaslipase, wirkt als wirksames Mittel gegen Fettleibigkeit.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 282526-98-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Cetilistat is an inhibitor of pancreatic and gastrointestinal lipases. It has great treatment of obesity in both diabetic and non-diabetic patients.
[1]. Andrew Bryson, Stephan de la Motte,et al. Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.Br J Clin Pharmacol. 2009 Mar; 67(3): 309-315. [2]. Melvin George, Muthukumar Rajaram,et al. New and Emerging Drug Molecules Against Obesity.J CARDIOVASC PHARMACOL THER January 2014 vol. 19 no. 1 65-76 [3]. Rebeca Carter, Angelina Mouralidarane,et al. Recent advancements in drug treatment of obesity.Clin Med October 1, 2012 vol. 12 no. 5 456-460
Average Rating: 5 (Based on Reviews and 13 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *